Markets

Achillion Pharmaceuticals (ACHN) Surges: Stock Moves 13.3% Higher - Tale of the Tape

Achillion Pharmaceuticals, Inc. ( ACHN ) was a big mover last session, as the company saw its shares rise over 13% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $3.26 to $3.47 since Dec 23, 2013.

The company has seen no estimate revision over the past 7 days and the Zacks Consensus Estimate remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Achillion Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Other players in the biotech industry, which look attractive at current levels, include Gentium S.p.A ( GENT ), Affymetrix Inc. ( AFFX ) and Alimera Sciences, Inc. ( ALIM ). While Affymetrix and Gentium carry a Zacks Rank #1 (Strong Buy), Alimera has a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.Click to get this free report >>

ACHILLION PHARM (ACHN): Free Stock Analysis Report

AFFYMETRIX INC (AFFX): Free Stock Analysis Report

ALIMERA SCIENCE (ALIM): Get Free Report

GENTIUM SPA-ADR (GENT): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

ALIM ACHN

Other Topics

Investing Stocks